U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Nuclear Pharmacy Guideline Criteria for Determining When to Register as a Drug Establishment
  1. Regulatory Information

GUIDANCE DOCUMENT

Nuclear Pharmacy Guideline Criteria for Determining When to Register as a Drug Establishment March 1998

Final

Nuclear Pharmacy Guideline Criteria for Determining When to Register as a Drug Establishment

Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

This guideline prepared by the Food and Drug Administration's Center for Drugs and Biologics states the criteria for determining when a nuclear pharmacy is required to register as a drug establishment.


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.